We’re in Chicago today attending the Chicago BioCapital Summit. Thank you to Wisconsin Alumni Research Foundation (WARF) for inviting us to represent Wisconsin innovation and biotech in the Hall of Inventions. If you’re at the event today, visit us at Table 89. https://lnkd.in/gXziGSA4 #venture #fundraising #biotech #innovation #uwmadison #onwisconsin #neuroscience
Stem Pharm
生物技术研究
Madison，Wisconsin 1,911 位关注者
Neuroinflammation-Focused Drug Discovery Using Human Organoids
关于我们
Stem Pharm is a neurological drug discovery platform company developing the next-generation of neurologic drugs using a human-first approach. Stem Pharm’s proprietary drug discovery platform is based on human 3D neuro-immune organoids that feature microglia and model neuroinflammation, which play a critical role in many neurological diseases. The company applies this platform to discover and validate disease targets and therapeutics for its internal programs in epilepsy, neurodegeneration, and brain cancer as well as for its biopharma partners’ therapeutic programs. Stem Pharm is based in Madison, WI, a hub for innovative stem cell and biosciences research.
- 网站
-
https://stempharm.com/
Stem Pharm的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Madison，Wisconsin
- 类型
- 私人持股
- 创立
- 2015
地点
-
主要
获取路线
5520 Nobel Dr
US，Wisconsin，Madison，53711
Stem Pharm员工
动态
-
#SfN24 is just around the corner and we're road tripping down I-90 to Chicago! Want to talk about neural organoids, microglia, neuroinflammation, and cell-based assays for CNS drug discovery? Stop by our posters Sunday and Monday and visit with our team, Connie Lebakken and Nina Y. Yuan. They’re eager for your questions! #letsconnect #neuroscience #drugdiscovery #organoids #neuroinflammation #microglia #ipsc #MEA
-
-
We are excited to announce that we’ve been awarded a Phase I NIH SBIR grant to advance drug discovery related to temporal lobe epilepsy (TLE). The grant will support the development of an innovative stem cell derived 3D neural organoid to model the role of microglia and neuroinflammation in TLE, ultimately paving the way for discovery of novel drug candidates. “We are honored to receive this SBIR grant from the NIH, which recognizes the potential impact of our work in advancing epilepsy research" - Dr. Steven Visuri, CEO of Stem Pharm. Read more --> https://lnkd.in/gf943qa6 #SBIR #innovation #organoids #neuroscience #epilepsy #neuroinflammation #microglia
-
Stem Pharm转发了
Neuroscience 2024 is just around the corner! We’re excited to announce that we are presenting 3 posters that will cover our latest results on application of neural organoids to study neuroinflammation. And one poster, in collaboration with our friends at Axion BioSystems, features a novel application of our SureCoat synthetic substrate technology to enhance neural cultures for MEA assays. #SfN24 #neuroscience #organoids #neuroinflammation #microglia #drugdiscovery
-
-
Neuroscience 2024 is just around the corner! We’re excited to announce that we are presenting 3 posters that will cover our latest results on application of neural organoids to study neuroinflammation. And one poster, in collaboration with our friends at Axion BioSystems, features a novel application of our SureCoat synthetic substrate technology to enhance neural cultures for MEA assays. #SfN24 #neuroscience #organoids #neuroinflammation #microglia #drugdiscovery
-
-
Welcome to the Moonshot Community, NeuroEM Therapeutics!
Join us in welcoming NeuroEM to our global Alzheimer's Moonshot Community! "We are honored to join such a transformative community and align with visionaries who are redefining the future of Alzheimer's care. Being part of the Moonshot Community lets us collaborate not only with a powerful network of top innovators across scientific disciplines, but also Moonshot Champions who are dedicating the resources necessary to move the needle on Alzheimer's research," says Chuck Papageorgiou, CEO, NeuroEM Therapeutics, pointing to the involvement of ADDF and Gates Ventures. He adds: "The Alzheimer's Moonshot Community is on the leading edge of research into the early detection and treatment of this devastating disease, and NeuroEM shares their commitment to advancing this mission. Together, we will accelerate the journey toward unlocking the secrets to a treatment and, one day, prevention and cure." #HealthTransformer #HealthMoonshot #AlzMoonshot https://ow.ly/UnNZ50Trpos
NeuroEM Therapeutics(R) Accepted into StartUp Health's Alzheimer's Moonshot Community(TM)
accesswire.com
-
Event alert!: Join our co-founder and COO Connie Lebakken at Careers and Beers hosted by @WARF tomorrow afternoon (September 12) at 5:00pm on the UW-Madison campus (Discovery Building). She’ll share her career experiences as an industrial scientist, entrepreneur and company founder. https://lnkd.in/gZHpy-3Y #onwisconsin #startups #uwmadison #biotech
Careers & Beers: Science and Entrepreneurship
https://www.warf.org
-
Are you attending the @LSXLeaders USA Congress in Boston this week? Our CEO, Steven Visuri, will present Stem Pharm at the Company Showcase on Thursday, September 12 at 12:15 pm EDT.?If you’re attending and on the partnering portal, schedule a meeting with us. Or if you’d like to meet outside of the conference, message us at [email protected]. #LSXUSA #biotech #drugdiscovery #Alzheimers #epilepsy #startups
-
-
Join us at the LSX USA Congress in Boston September 11-12. Our CEO, Steven Visuri, will present Stem Pharm at the Company Showcase on Thursday, September 12 at 12:15 pm EDT.?If you’re attending and on the partnering portal, schedule a meeting with us. Or if you’d like to meet outside of the conference, message us at [email protected]. LSX USA Congress gathers the founders and CEOs of innovative biotech, medtech and healthtech start-ups through to healthcare giants, and everyone in between. They attend alongside the sector’s most active investors, pharma, medtech and healthtech BD&L teams and R&D leaders. Find out more: https://lnkd.in/g3e8QD_x #LSXUSA #biotech #drugdiscovery #Alzheimers #epilepsy #startups
-
-
Meet our team and backstory in this fantastic piece by StartUp Health. #Alzheimers #organoid #drugdiscovery #neuroinflammation #startup
A team of scientists and entrepreneurs have developed a superior “brain-in-a-dish” platform that makes the development of therapeutics for diseases like Alzheimer’s and epilepsy much more likely to succeed. #HealthTransformer #HealthMoonshot #AlzMoonshot ?? Meet Stem Pharm ?? https://ow.ly/Ohf250T5onM
Stem Pharm Is Revolutionizing Drug Discovery for Brain Diseases — StartUp Health
startuphealth.com